BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11761821)

  • 1. [The effect of triamcinolone, montelukast and formoterol on serum levels of il-4, IgE and clinical parameters in children with asthma].
    Stelmach I; Grzelewski T; Majak P; Majak J; Bobrowska M; Jerzyńska J; Kuna P
    Pol Merkur Lekarski; 2001 Sep; 11(63):247-51. PubMed ID: 11761821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children].
    Stelmach I; Jerzyńska J; Majak P; Grzelewski T; Górski P; Stelmach W; Kuna P
    Pol Merkur Lekarski; 2002 Feb; 12(68):99-103. PubMed ID: 11995262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children].
    Stelmach I; Grzelewski T; Stelmach W; Majak P; Jerzyńska J; Górski P; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of nedocromil sodium on levels of IL-4 and IgE in serum of children with bronchial asthma].
    Stelmach I; Grzelewski T; Stelmach W; Majak P; Jerzyńska J; Górski P; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):214-7. PubMed ID: 12053591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
    Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
    Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
    Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IL-10 serum levels in children with moderate asthma].
    Stelmach I; Jerzyńska J; Bobrowska M; Brzozowska A; Majak P; Kuna P
    Pneumonol Alergol Pol; 2002; 70(1-2):25-33. PubMed ID: 12148173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
    Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
    Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma.
    Stelmach I; Grzelewski T; Majak P; Jerzynska J; Stelmach W; Kuna P
    J Allergy Clin Immunol; 2008 Feb; 121(2):383-9. PubMed ID: 17980416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide.
    Stelmach I; Jerzynska J; Kuna P
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):319-26. PubMed ID: 11686425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
    Stelmach I; Majak P; Jerzynska J; Stelmach W; Kuna P
    Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma.
    Stelmach I; Grzelewski T; Bobrowska-Korzeniowska M; Stelmach P; Kuna P
    Pulm Pharmacol Ther; 2007; 20(6):691-700. PubMed ID: 17046300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of asthma therapy alternatives and evaluating the effectivity of asthma therapy by interleukin-13 and interferon gamma levels in children.
    Karaman O; Arli O; Uzuner N; Islekel H; Babayigit A; Olmez D; Kose S; Tezcan D
    Allergy Asthma Proc; 2007; 28(2):204-9. PubMed ID: 17479606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.